AA Genotype Exacerbates Effect of Diabetes on Dementia and Alzheimer Disease: A Population-Based Longitudinal Study

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5: 64–74. doi: 10.1016/S1474-4422(05)70284-2 16361024

2. Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42: 484–491. doi: 10.1111/j.1445-5994.2012.02758.x 22372522

3. Lu FP, Lin KP, Kuo HK (2009) Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS ONE 4: e4144. doi: 10.1371/journal.pone.0004144 19127292

4. Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes 56: 211–216. doi: 10.2337/db06-0879 17192484

5. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, et al. (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63: 658–663. doi: 10.1212/01.WNL.0000134666.64593.BA 15326238

6. Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer’s disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33: 1041–1044. doi: 10.1042/BST20051041 16246041

7. Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer’s disease: review and hypothesis. Neurobiol Aging 27: 190–198. doi: 10.1016/j.neurobiolaging.2005.01.004 16399206

8. Kuo WL, Gehm BD, Rosner MR, Li W, Keller G (1994) Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. J Biol Chem 269: 22599–22606. 8077210

9. Williama FG, Johnson DE, Bauer GE (1990) [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation. Metabolism 39: 231–241. doi: 10.1016/0026-0495(90)90041-A 2407925

10. Hong MG, Reynolds C, Gatz M, Johansson B, Palmer JC, et al. (2008) Evidence that the gene encoding insulin degrading enzyme influences human lifespan. Hum Mol Genet 17: 2370–2378. doi: 10.1093/hmg/ddn137 18448515

11. Prince JA, Feuk L, Gu HF, Johansson B, Gatz M, et al. (2003) Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 22: 363–371. doi: 10.1002/humu.10282 14517947

12. Rudovich N, Pivovarova O, Fisher E, Fischer-Rosinsky A, Spranger J, et al. (2009) Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes. J Mol Med (Berl) 87: 1145–1151. doi: 10.1007/s00109-009-0540-6

13. Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, et al. (2003) Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52: 1562–1567. doi: 10.2337/diabetes.52.6.1562 12765971

14. Sato N, Ueki A, Ueno H, Shinjo H, Morita Y (2008) IDE gene polymorphism influences on BPSD in mild dementia of Alzheimer’s type. Curr Gerontol Geriatr Res 2008: 858759. doi: 10.1155/2008/858759

15. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63: 1181–1186. doi: 10.1212/01.WNL.0000140291.86406.D1 15477535

16. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L (2009) Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study. Diabetologia 52: 1031–1039. doi: 10.1007/s00125-009-1323-x 19280172

17. Xu WL, Caracciolo B, Wang HX, Winblad B, Backman L, et al. (2010) Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 59: 2928–2935. doi: 10.2337/db10-0539 20713684

18. Xu WL, Qiu C, Gatz M, Pedersen NL, Johansson B, et al. (2009) Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58: 71–77. doi: 10.2337/db08-0586 18952836

19. Björk BF, Katzov H, Kehoe P, Fratiglioni L, Winblad B, et al. (2007) Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE. Neurobiol Aging 28: 1374–1380. doi: 10.1016/j.neurobiolaging.2006.06.017 16876916

20. Alzforum. AlzGene—polymorphism details. Available: http://www.alzgene.org/polydetail.asp?geneID=124&studyID=511&ethnicDataID=715. Accessed 10 June 2015.

21. Fratiglioni L, Viitanen M, Backman L, Sandman PO, Winblad B (1992) Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 11 (Suppl 1): 29–36. 1603245

22. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, third edition–revised (DSM-III-R). Washington (District of Columbia): American Psychiatric Association.

23. Lagergren M, Fratiglioni L, Hallberg IR, Berglund J, Elmstahl S, et al. (2004) A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin Exp Res 16: 158–168. 15195992

24. Qiu C, Backman L, Winblad B, Aguero-Torres H, Fratiglioni L (2001) The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol 58: 2034–2039. doi: 10.1001/archneur.58.12.2034 11735777

25. Qiu CX, Winblad B, Marengoni A, Klarin I, Fastbom J, et al. (2006) Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med 166: 1003–1008. doi: 10.1001/archinte.166.9.1003 16682574

26. Nordic Council on Medicines (1985) Guidelines for ATC classification. NLN publication no. 16. Uppsala (Sweden): Nordic Council on Medicines.

27. Goodall I (2005) HbA1c standardisation destination—global IFCC standardisation. How, why, where and when—a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes. Clin Biochem Rev 26: 5–19. 16278773

28. World Health Organization (1999) Definition, diabetes and classification of diabetes mellitus and its complications. Geneva: World Health Organization.

29. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33: S62–S69. doi: 10.2337/dc10-S062 20042775

30. Mueller JC, Riemenschneider M, Schoepfer-Wendels A, Gohlke H, Konta L, et al. (2007) Weak independent association signals between IDE polymorphisms, Alzheimer’s disease and cognitive measures. Neurobiol Aging 28: 727–734. doi: 10.1016/j.neurobiolaging.2006.03.009 16675064

31. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Winblad B (1992) Clinical diagnosis of Alzheimer’s disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, criteria. Arch Neurol 49: 927–932. doi: 10.1001/archneur.1992.00530330049015 1520083

32. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944. 6610841

33. Wang R, Fratiglioni L, Laveskog A, Kalpouzos G, Ehrenkrona CH, et al. (2014) Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study. Eur J Neurol 21: 1076–1082. doi: 10.1111/ene.12319 24313901

34. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26: 839–851. doi: 10.1016/j.neuroimage.2005.02.018 15955494

35. Zhang Y, Qiu C, Lindberg O, Bronge L, Aspelin O, et al. (2010) Acceleration of hippocampal atrophy in a non-demented elderly population: the SNAC-K study. Int Psychogeriatr 22: 14–25. doi: 10.1017/S1041610209991396 19958567

36. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, et al. (2005) Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 15: 1676–1689. doi: 10.1093/cercor/bhi044 15703252

37. Andersson DK, Svardsudd K, Tibblin G (1991) Prevalence and incidence of diabetes in a Swedish community 1972–1987. Diabet Med 8: 428–434. 1830526

38. Jansson SP, Andersson DK, Svardsudd K (2007) Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 50: 703–710. doi: 10.1007/s00125-007-0593-4 17268796

39. Xu WL (2008) Diabetes mellitus and the risk of dementia: a population-based study [PhD dissertation]. Stockholm (Sweden): Karolinska Institutet. Available: http://diss.kib.ki.se/2008/978-91-7357-516-4/. Accessed 10 June 2015.

40. Rydwik E, Welmer AK, Kareholt I, Angleman S, Fratiglioni L, et al. (2013) Adherence to physical exercise recommendations in people over 65—the SNAC-Kungsholmen study. Eur J Public Health 23: 799–804. doi: 10.1093/eurpub/cks150 23115329

41. Marlowe L, Peila R, Benke KS, Hardy J, White LR, et al. (2006) Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk. Neurodegener Dis 3: 320–326. doi: 10.1159/000097300 17192720

42. Runyan K, Duckworth WC, Kitabchi AE, Huff G (1979) The effect of age on insulin-degrading activity in rat tissue. Diabetes 28: 324–325. doi: 10.2337/diab.28.4.324 437372

43. Cheng H, Wang L, Shi T, Shang Y, Jiang L (2014) Association of insulin degrading enzyme gene polymorphisms with Alzheimer’s disease: a meta-analysis. Int J Neurosci. E-pub ahead of print. doi: 10.3109/00207454.2014.941440

44. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881–885. doi: 10.1038/nature05616 17293876

45. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341–1345. doi: 10.1126/science.1142382 17463248

46. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336–1341. doi: 10.1126/science.1142364 17463249

47. Ali S, Chopra R, Manvati S, Singh YP, Kaul N, et al. (2013) Replication of type 2 diabetes candidate genes variations in three geographically unrelated Indian population groups. PLoS ONE 8: e58881. doi: 10.1371/journal.pone.0058881 23527042

48. Gu HF, Efendic S, Nordman S, Ostenson CG, Brismar K, et al. (2004) Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 53: 2137–2142. doi: 10.2337/diabetes.53.8.2137 15277398

49. Florez JC, Wiltshire S, Agapakis CM, Burtt NP, de Bakker PI, et al. (2006) High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes 55: 128–135. doi: 10.2337/diabetes.55.01.06.db05-0954 16380485

50. Bartl J, Scholz CJ, Hinterberger M, Jungwirth S, Wichart I, et al. (2011) Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene. BMC Med Genet 12: 151. doi: 10.1186/1471-2350-12-151 22107728

51. Nordman S, Ostenson CG, Efendic S, Gu HF (2009) Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes. Exp Clin Endocrinol Diabetes 117: 186–190. doi: 10.1055/s-0028-1100419 19053027

52. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, et al. (2012) Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 90: 410–425. doi: 10.1016/j.ajhg.2011.12.022 22325160

53. Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath JR, et al. (2000) Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet 9: 2149–2158. doi: 10.1093/hmg/9.14.2149 10958757

54. Farris W, Mansourian S, Leissring MA, Eckma EA, Bertram L, et al. (2004) Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164: 1425–1434. doi: 10.1016/S0002-9440(10)63229-4 15039230

55. Zhao WQ, Townsend M (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim Biophys Acta 1792: 482–496. doi: 10.1016/j.bbadis.2008.10.014 19026743

56. Finotello F, Di Camillo B (2015) Measuring differential gene expression with RNA-seq: challenges and strategies for data analysis. Brief Funct Genomics 14:130–142. doi: 10.1093/bfgp/elu035 25240000